Economic Impact of Treatment with Novel oral Anticoagulants Versus Warfarin in Brazilian Private Health System

Abstract

with drug-eluting stent placement cost an average of 47,053.16, patients with acute myocardial infarction who underwent revascularization cost an average of 55,585.20, patients with acute myocardial infarction who underwent revascularization and angioplasty with drug-eluting stent placement cost an average of 57,391.90, and patients with acute myocardial infarction who underwent angioplasty with drugeluting stent placement cost an average of 58,476.30. ConClusions: Private health insurances in Brazil provide treatment only for hospitalized patients instead of covering prophylactic drug treatment, a practice that might lead to higher expenditure on hospitalization and procedures for unmanaged cardiovascular diseases, where costs can range from 24,175.49 up to 58,476.30, an increase of 41%.